デフォルト表紙
市場調査レポート
商品コード
1089763

臨床試験機器・付属ソリューションの世界市場:製品別、タイプ別、フェーズ別、治療領域別、最終用途別、地域別、2027年までの予測 - COVID-19の累積的影響

Clinical Trial Equipment & Ancillary Solutions Market Research Report by Product, Type, Phase, Therapeutic Area, End use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
臨床試験機器・付属ソリューションの世界市場:製品別、タイプ別、フェーズ別、治療領域別、最終用途別、地域別、2027年までの予測 - COVID-19の累積的影響
出版日: 2022年06月15日
発行: 360iResearch LLP
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験機器・付属ソリューションの市場規模は、8.21%のCAGRで推移し、2027年までに38億4,012万米ドルに達すると予測されています。

当レポートでは、世界の臨床試験機器・付属ソリューション市場について調査し、市場の促進要因、抑制要因、市場機会、課題、製品別・タイプ別・フェーズ別・治療領域別・最終用途別・地域別の市場分析、競合情勢、企業プロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーション・範囲
  • 調査対象期間
  • 通貨・価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 臨床試験機器・付属ソリューション市場:製品別

  • サービス
    • キャリブレーション
    • 機器整備
  • 調達
    • 購買
    • レンタル
  • 供給/物流
    • 包装
    • 輸送

第7章 臨床試験機器・付属ソリューション市場:タイプ別

  • 生物学的製剤
  • 医療機器
  • 小分子

第8章 臨床試験機器・付属ソリューション市場:フェーズ別

  • フェーズ1
  • フェーズ2
  • フェーズ3
  • フェーズ4

第9章 臨床試験機器・付属ソリューション市場:治療領域別

  • 血液疾患
  • 心血管疾患
  • 中枢神経系・精神障害
  • 消化器疾患
  • 免疫
  • 感染症
  • 代謝障害
  • 腫瘍

第10章 臨床試験機器・付属ソリューション市場:最終用途別

  • 開発業務受託機関(CRO)
  • 医療機器企業
  • 製薬・バイオテクノロジー企業

第11章 南北アメリカの臨床試験機器・付属ソリューション市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋の臨床試験機器・付属ソリューション市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第13章 欧州、中東・アフリカの臨床試験機器・付属ソリューション市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 合併・買収
    • 合意・コラボレーション・パートナーシップ
    • 新製品の発売・強化
    • 投資・資金調達
    • 評価・認知・拡大

第15章 企業のユーザビリティプロファイル

  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Emsere B.V.
  • Eurofins Scientific
  • Imperial Clinical Research Services, Inc.
  • IRM Europe
  • Marken, a UPS Company
  • Myonex, Inc.
  • Parexel International Corporation
  • Piramal Pharma Solutions
  • Quipment SAS
  • Recipharm AB
  • Thermo Fisher Scientific, Inc.
  • Woodley Equipment Company Ltd.

第16章 付録

  • ディスカッションガイド
  • ライセンス・価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: DYNAMICS
  • FIGURE 2. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2027
  • FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, 2019-2027 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, 2019-2027 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, 2019-2027 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, 2019-2027 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, 2019-2027 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, 2019-2027 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, 2019-2027 (USD MILLION)
  • FIGURE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, 2019-2027 (USD MILLION)
  • FIGURE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, 2019-2027 (USD MILLION)
  • FIGURE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
  • FIGURE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2027
  • FIGURE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, 2019-2027 (USD MILLION)
  • FIGURE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, 2019-2027 (USD MILLION)
  • FIGURE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, 2019-2027 (USD MILLION)
  • FIGURE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2021 VS 2027 (%)
  • FIGURE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2021 VS 2027 (USD MILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2027
  • FIGURE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, 2019-2027 (USD MILLION)
  • FIGURE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, 2019-2027 (USD MILLION)
  • FIGURE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, 2019-2027 (USD MILLION)
  • FIGURE 40. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 41. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, 2019-2027 (USD MILLION)
  • FIGURE 42. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 43. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
  • FIGURE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2027
  • FIGURE 46. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, 2019-2027 (USD MILLION)
  • FIGURE 47. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 48. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD MILLION)
  • FIGURE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, 2019-2027 (USD MILLION)
  • FIGURE 51. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 52. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, 2019-2027 (USD MILLION)
  • FIGURE 53. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 54. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, 2019-2027 (USD MILLION)
  • FIGURE 55. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 56. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD MILLION)
  • FIGURE 57. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 58. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, 2019-2027 (USD MILLION)
  • FIGURE 59. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 60. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
  • FIGURE 61. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 62. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END USE, 2021 VS 2027 (%)
  • FIGURE 63. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END USE, 2021 VS 2027 (USD MILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END USE, 2027
  • FIGURE 65. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 (USD MILLION)
  • FIGURE 66. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 67. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, 2019-2027 (USD MILLION)
  • FIGURE 68. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 69. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
  • FIGURE 70. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 71. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 72. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 73. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 74. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 75. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 76. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 77. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 78. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 79. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 80. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 81. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 82. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 83. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 84. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 85. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 86. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 87. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 88. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 89. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 90. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 91. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 92. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 93. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 94. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 95. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 96. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 97. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 98. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 99. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 100. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 101. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 102. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 103. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 6. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 7. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 10. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 12. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CALIBRATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 15. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 16. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 17. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT SERVICING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 20. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 21. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 22. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SOURCING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 25. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 26. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 28. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 30. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 31. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 33. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RENTAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 35. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 36. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 38. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY/LOGISTICS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 40. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 41. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 43. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 46. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 48. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 51. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 52. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 56. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 57. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 61. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 62. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2019-2027 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 67. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 68. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 72. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 73. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 76. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 77. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 81. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 82. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 83. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 86. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
  • TABLE 87. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 88. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 89. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 92. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 93. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 94. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 97. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 98. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 99. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 102. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 103. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 104. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 107. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 108. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 109. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 112. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 113. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 114. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 117. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 118. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 119. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 122. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 123. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 124. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 127. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END USE, 2019-2027 (USD MILLION)
  • TABLE 128. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2019-2027 (USD MILLION)
  • TABLE 129. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 130. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY STATE, 2019-2027 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 133. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 134. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 135. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 138. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 139. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 140. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 143. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 144. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 145. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 146. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 147. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 148. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 150. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 151. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 152. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 153. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 154. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 155. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 156. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 157. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 158. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 159. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 160. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 162. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 163. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 164. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 165. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 166. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 167. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 168. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 169. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 170. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 171. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 172. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 173. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: SCORES
  • TABLE 174. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: BUSINESS STRATEGY
  • TABLE 175. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: PRODUCT SATISFACTION
  • TABLE 176. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: RANKING
  • TABLE 177. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 178. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: MERGER & ACQUISITION
  • TABLE 179. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 180. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 181. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: INVESTMENT & FUNDING
  • TABLE 182. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 183. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: LICENSE & PRICING
目次
Product Code: MRR-8C74ADFC1267

The Global Clinical Trial Equipment & Ancillary Solutions Market grew USD 3,840.12 million by 2027, at a CAGR of 8.21%.

The Global Clinical Trial Equipment & Ancillary Solutions Market size was estimated at USD 2,391.23 million in 2021 and expected to reach USD 2,581.57 million in 2022, and is projected to grow at a CAGR 8.21% to reach USD 3,840.12 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trial Equipment & Ancillary Solutions to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Service, Sourcing, and Supply/Logistics. The Service is further studied across Calibrations and Equipment Servicing. The Sourcing is further studied across Procurement and Rental. The Supply/Logistics is further studied across Packaging and Transportation.

Based on Type, the market was studied across Biologic Drugs, Medical Devices, and Small Molecules.

Based on Phase, the market was studied across Phase I, Phase II, Phase III, and Phase IV.

Based on Therapeutic Area, the market was studied across Blood Disorders, Cardiovascular Diseases, Cns & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology.

Based on End use, the market was studied across Contract Research Organizations (CROs), Medical Devices Companies, and Pharmaceutical & Biotechnology companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trial Equipment & Ancillary Solutions market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Equipment & Ancillary Solutions Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Equipment & Ancillary Solutions Market, including Almac Group Limited, Ancillare, LP, Avantor, Inc., Emsere B.V., Eurofins Scientific, Imperial Clinical Research Services, Inc., IRM Europe, Marken, a UPS Company, Myonex, Inc., Parexel International Corporation, Piramal Pharma Solutions, Quipment SAS, Recipharm AB, Thermo Fisher Scientific, Inc., and Woodley Equipment Company Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Clinical Trial Equipment & Ancillary Solutions Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Equipment & Ancillary Solutions Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Equipment & Ancillary Solutions Market?
  • 4. What is the competitive strategic window for opportunities in the Global Clinical Trial Equipment & Ancillary Solutions Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Equipment & Ancillary Solutions Market?
  • 6. What is the market share of the leading vendors in the Global Clinical Trial Equipment & Ancillary Solutions Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Equipment & Ancillary Solutions Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing government expenditure in healthcare industry worldwide
      • 5.1.1.2. Rising emergence of new and rare disorders
      • 5.1.1.3. Outsourcing of clinical trial activity across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Elevation in cost of drug development and clinical trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation in numbers of regulatory approvals with favorable governmental support
      • 5.1.3.2. Rise in the number of CRO and pharmaceutical & medical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in procedures of cross border logistics challenging clinical trials
  • 5.2. Cumulative Impact of COVID-19

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

  • 6.1. Introduction
  • 6.2. Service
    • 6.2.1. Calibrations
    • 6.2.2. Equipment Servicing
  • 6.3. Sourcing
    • 6.3.1. Procurement
    • 6.3.2. Rental
  • 6.4. Supply/Logistics
    • 6.4.1. Packaging
    • 6.4.2. Transportation

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

  • 8.1. Introduction
  • 8.2. Phase I
  • 8.3. Phase II
  • 8.4. Phase III
  • 8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. Cns & Mental Disorders
  • 9.5. Digestive Disorders
  • 9.6. Immunology
  • 9.7. Infectious Diseases
  • 9.8. Metabolic Disorders
  • 9.9. Oncology

10. Clinical Trial Equipment & Ancillary Solutions Market, by End use

  • 10.1. Introduction
  • 10.2. Contract Research Organizations (CROs)
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology companies

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

  • 13.1. Introduction
  • 13.2. France
  • 13.3. Germany
  • 13.4. Italy
  • 13.5. Netherlands
  • 13.6. Qatar
  • 13.7. Russia
  • 13.8. Saudi Arabia
  • 13.9. South Africa
  • 13.10. Spain
  • 13.11. United Arab Emirates
  • 13.12. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
    • 14.1.1. Quadrants
    • 14.1.2. Business Strategy
    • 14.1.3. Product Satisfaction
  • 14.2. Market Ranking Analysis
  • 14.3. Market Share Analysis, By Key Player
  • 14.4. Competitive Scenario
    • 14.4.1. Merger & Acquisition
    • 14.4.2. Agreement, Collaboration, & Partnership
    • 14.4.3. New Product Launch & Enhancement
    • 14.4.4. Investment & Funding
    • 14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles

  • 15.1. Almac Group Limited
  • 15.2. Ancillare, LP
  • 15.3. Avantor, Inc.
  • 15.4. Emsere B.V.
  • 15.5. Eurofins Scientific
  • 15.6. Imperial Clinical Research Services, Inc.
  • 15.7. IRM Europe
  • 15.8. Marken, a UPS Company
  • 15.9. Myonex, Inc.
  • 15.10. Parexel International Corporation
  • 15.11. Piramal Pharma Solutions
  • 15.12. Quipment SAS
  • 15.13. Recipharm AB
  • 15.14. Thermo Fisher Scientific, Inc.
  • 15.15. Woodley Equipment Company Ltd.

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing